Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
复制标题
DOI:
10.1093/eurheartj/ehy334
复制
发表时间:
2018-07-14
影响因子:
39.3
通讯作者:
Stroes ESG
中科院分区:
文献类型:
--
作者:
Verbeek R;Hoogeveen RM;Langsted A;Stiekema LCA;Verweij SL;Hovingh GK;Wareham NJ;Khaw KT;Boekholdt SM;Nordestgaard BG;Stroes ESG
Lipoprotein(a) [Lp(a)] elevation is a causal risk factor for cardiovascular disease (CVD). It has however been suggested that elevated Lp(a) causes CVD mainly in individuals with high low-density lipoprotein cholesterol (LDL-C) levels. We hypothesized that the risk associated with high Lp(a) levels would largely be attenuated at low LDL-C levels. In 16,654 individuals from the EPIC-Norfolk prospective population study and in 9,448 individuals from the Copenhagen City Heart Study (CCHS) parallel statistical analyses were performed. Individuals were categorized according to their Lp(a) and LDL-C levels. Cut-offs were set at the 80th cohort percentile for Lp(a). LDL-C cut-offs were set at 2.5, 3.5, 4.5 and 5.5 mmol/L. LDL-C levels in the primary analyses were corrected for Lp(a)-derived LDL-C (LDL-Ccorr). Multivariable-adjusted hazard ratios (HR) were calculated for each category. The category with LDL-Ccorr <2.5 mmol/L and Lp(a) <80th cohort percentile was used as reference category. In the EPIC-Norfolk and CCHS cohorts, individuals with an Lp(a) ≥80th percentile were at increased CVD risk compared to those with Lp(a) <80th percentile for any LDL-Ccorr levels ≥2.5 mmol/L. In contrast, for LDL-Ccorr <2.5 mmol/L, the risk associated with elevated Lp(a) attenuated. However, there was no interaction between LDL-Ccorr and Lp(a) levels on CVD risk in either cohort. Lp(a) and LDL-C are independently associated with CVD risk. At LDL-C levels below <2.5 mmol/L, the risk associated with elevated Lp(a) attenuates in a primary prevention setting.
登录
查看更多内容
影响因子:
37.8
作者:
Khera AV;Everett BM;Caulfield MP;Hantash FM;Wohlgemuth J;Ridker PM;Mora S
通讯作者:
Mora S
影响因子:
120.7
作者:
Erqou, Sebhat;Kaptoge, Stephen;Perry, Philip L.;Di Angelantonio, Emanuele;Thompson, Alexander;White, Ian R.;Marcovina, Santica M.;Collins, Rory;Thompson, Simon G.;Danesh, John
通讯作者:
Danesh, John
影响因子:
6.2
作者:
Anderson, Todd J.;Gregoire, Jean;Ward, Richard
通讯作者:
Ward, Richard
影响因子:
39.3
作者:
Nordestgaard BG;Chapman MJ;Ray K;Borén J;Andreotti F;Watts GF;Ginsberg H;Amarenco P;Catapano A;Descamps OS;Fisher E;Kovanen PT;Kuivenhoven JA;Lesnik P;Masana L;Reiner Z;Taskinen MR;Tokgözoglu L;Tybjærg-Hansen A;European Atherosclerosis Society Consensus Panel
通讯作者:
European Atherosclerosis Society Consensus Panel
影响因子:
37.8
作者:
Kamstrup, Pia R.;Benn, Marianne;Nordestgaard, Borge G.
通讯作者:
Nordestgaard, Borge G.